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ScienceDirectAnatomy of a crosslinker
Adam Belsom1 and Juri Rappsilber1,2Abstract
Crosslinking mass spectrometry has become a core technol-
ogy in structural biology and is expanding its reach towards
systems biology. Its appeal lies in a rapid workflow, high
sensitivity and the ability to provide data on proteins in complex
systems, even in whole cells. The technology depends heavily
on crosslinking reagents. The anatomy of crosslinkers can be
modular, sometimes comprising combinations of functional
groups. These groups are defined by concepts including: re-
action selectivity to increase information density, enrichability
to improve detection, cleavability to enhance the identification
process and isotope-labelling for quantification. Here, we
argue that both concepts and functional groups need more
thorough experimental evaluation, so that we can show exactly
how and where they are useful when applied to crosslinkers.
Crosslinker design should be driven by data, not only con-
cepts. We focus on two crosslinker concepts with large con-
sequences for the technology, namely reactive group reaction
kinetics and enrichment groups.
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Crosslinking mass spectrometry (MS) technology and
its applications have been reviewed extensively [1e6],
which includes subdisciplines providing high-density
crosslinking data [7,8] and quantitative crosslinking
data [9]. Here, we would like to turn the spotlight backwww.sciencedirect.comonto the crosslinking reagent, focussing on the multiple
aspects of chemical structure and reactivity that these
applications depend upon.
Protein crosslinking predates the electrospray-ionisation
MS that is used routinely nowadays for its detection, by
30 years. The first identification of a crosslink (via paper
chromatography) in 1958 by Zahn et al. was made
following the use of a Sanger’s reagent derivative 1,5-
difluoro-2,4-dinitrobenzene (Figure 1) on insulin
[10,11]. Since this time, there has been an explosion of
protein crosslinking reagents available and something of
an evolution/revolution in the chemicals used specif-
ically for crosslinking-MS [12].
The range of available reagents and the chemistry and
diverse functionality that can be incorporated within
them is so great that it becomes impossible to review
them on a case-by-case basis (to date, SigmaeAldrich
lists 268 crosslinkers, Thermo Fisher Scientific lists
104 crosslinkers, crosslinkers are also not a part of
standardisation efforts in crosslinking-MS [https://arxiv.
org/abs/2007.00383]). Instead, the crosslinking reagent
can rather be dissected, understood and discussed in
terms of its constituent parts. Note that ‘zero-length’
crosslinkers [13,14], reactive oxygen species [15] and
metal-induced redox reactions [16], and photo-
activatable noncanonical amino acids [17] can lead to
crosslinks. However, the largest individual group of
crosslinking reagents, which is also the most used for
crosslinking-MS today, comprises molecules with func-
tional groups, whereby at least two of the groups are
reactive and capable of conjugation, which are them-
selves separated by a group functioning as a spacer or
distance restraint (Figure 2). The simplest examples of
this type include disuccinimidyl suberate (DSS) and
bis(sulfosuccinimidyl)suberate (BS3) (NHS and sulfo-
NHS esters, respectively), where the spacer consti-
tutes a straightforward alkyl chain (Figure 1).
Despite the large selection of available crosslinkers, and
their predating crosslinking-MS by nearly two decades,
DSS [18] and BS3 [19] have become the go-to reagents
of choice [6]. This was also evidenced in a recent
interlaboratory study where the majority of participating
labs chose DSS/BS3 (35/57 data sets) [20]. The choice
is understandable considering the huge range of appli-
cations and successes using DSS/BS3, including inte-
grative structural biology in purified complexes [21],Current Opinion in Chemical Biology 2021, 60:39–46
Figure 1
Evolution of crosslinkers. Reactive groups are highlighted in magenta. (a)
1,5-difluoro-2,4-dinitrobenzene (DFDNB), the first crosslinker applied to
protein analysis. (b) Bis(sulfosuccinimidyl)suberate (BS3), which together
with its nonsulfonated form disuccinimidyl suberate (DSS), are currently
the most commonly used crosslinkers. (c) Protein interaction reporter
(PIR), a large, multifunctional crosslinker. This crosslinker contains an
MS-cleavable Rink group (highlighted in grey, cleavable bonds indicated
by black dashed lines) and an enrichable biotin group (highlighted in
cyan). MS, mass spectrometry.
Figure 2
Crosslinking reagent anatomy. Requisite features are shown in red.
Optional features are highlighted in grey. Many different reactive groups
and spacer scaffolds, and multiple different cleavable, releasable and
enrichable groups are in use. Even more can be imagined or will be
developed in the future. The resulting combinatorial complexity has
already resulted in a large number of crosslinkers and allows for an even
larger number of future crosslinkers. Reagents are typically only demon-
strated in proof-of-principle, although some also in biological applications.
However, the actual benefit of most of these reagents for crosslinking-MS
has not been assessed rigorously. MS, mass spectrometry.
40 Omicsorganelles [22,23] and in cells [24], and both labelled
[25,26] and label-free [27] quantitation for analysing
protein structural changes [9,28].
The simplicity of DSS/BS3, reaction specificity, ease-of-
use, reaction product stability and lack of reaction by-
products, all contribute to the tremendous success of
these reagents. However, an overreliance on this specific
reactive group chemistry significantly limits theCurrent Opinion in Chemical Biology 2021, 60:39–46information density of crosslinking and may mislead
structural analysis as we will discuss in the following
context. Furthermore, there is significantly more to
crosslinker design than only protein reactive groups.
In this review, we give a general overview of the array of
functional groups found in crosslinking reagents. We
propose that crosslinker design has been led by con-
cepts, including reactive group specificity, cleavability to
enhance identification and enrichability to improve
detection. We argue that currently the enthusiasm for
concepts pushes the design of new reagents. As
appealing as concepts can be, they still must be
underpinned by data. Ultimately, it is the data that
reveal, where further improvements are required. After
all, it is data that crosslinking-MS feeds, into structural
and systems biology.Reactive groups
The NHS-ester (and derivatives) is found ubiquitously
in crosslinking reagents. Its reaction specificity in pro-
teins is well characterised, preferentially reacting with
amines from lysine side chains and protein N-
termini but also with hydroxyl groups from the side
chains of serine, threonine and tyrosine, at physiological
conditions [29,30]. This confined specificity, predomi-
nantly towards pairs of proximal lysine residues, limits
the numbers of distance restraints that can be intro-
duced into proteins; hence data are sparse and low-
resolution. Data density can be increased by expand-
ing reactivity to target other amino acid residues,www.sciencedirect.com
Anatomy of a crosslinker Belsom and Rappsilber 41including employment of aromatic glyoxal groups for
arginine-targeting [31] and dihydrazides/diazo-
derivatives targeting carboxylic acids [32e34].
Expanding reactivity even further, to all amino acids, has
led to the greatest leap towards increasing data density
so far (Figure 3), via crosslinkers containing photo-
activatable reactive groups including diazirine (sulfo-
SDA/SDA) [35] and benzophenone (sulfo-SBP/SBP)
[36]. Upon activation by ultraviolet irradiation, the
resulting reactive radical intermediates react promiscu-
ously and readily with any proximal NeH and CeH
bonds. These all-amino-acid-targeting photoactivatable
groups are combined with highly amino acidespecific
NHS-ester groups into heterobifunctional, semispecific
crosslinkers. Protein crosslinking becomes a two-stage
reaction: First, the NHS-ester groups decorate pro-
teins specifically on nucleophiles (as previously
described). Second, photoactivation completes cross-
linking, to any part of a protein within a crosslinkable
distance. Similar to the reaction products of homo-
bifunctional, NHS-ester crosslinkers BS3/DSS, the
beauty of the reaction products of the diazirine in sulfo-
SDA, lies in their simplicity. The spacer group intro-
duced is a short, 4-carbon, alkyl chain (3.9 A spacer
length, compared with 11.4 A for BS3/DSS). The
crosslinked products from use of photoactivatable
benzophenone on the other hand, retain the aromatic
groups. Interestingly, there is evidence of complemen-
tarity between crosslinked products with diazirine and
benzophenone [36], despite involving the same
anchoring residues. The influence of crosslinker spacer
composition and conformational preference is an aspect
of reagents that is being actively studied [37,38].
Semispecific, heterobifunctional crosslinkers can in-
crease data density (not crosslinks per protein mole-
cule) by orders of magnitude, compared with amino
acidespecific, homobifunctional crosslinkers (a cross-
laboratory study reported 44 crosslinks for monomeric
BSA summed from three liquid chromatography (LC)-
MS runs, as an average of the participating labs, whereas
sulfo-SDA yielded 311 in a single LC-MS run [20]). The
work carried out by our laboratory demonstrated the
implication of this on one of the original application
fields of crosslinking-MS, resolving detailed tertiary
protein structure [8,35]. Indeed, high-density data
using semispecific crosslinkers can improve protein-
structure predictions [35] and routine implementation
is intensely investigated [7,8,39e42]. This work
inspired a number of other works in pursuit of this same
ambition [41e44]. Further studies continue to demon-
strate the benefits of semispecific crosslinkers in protein
complexes [45]. The costs involved with the use of
semispecific crosslinkers are the increased needs for
high-quality MS and MS/MS data, and robust database
search and respective false-discovery rate [46e49]
determination pipelines [28,50]. The same is also truewww.sciencedirect.comwherever the scope of crosslinked products is expanded,
including proteome-wide analyses [51e53].
An oft-mentioned concern in crosslinking-MS is the
occurrence of artefacts, especially for photocrosslinkers
[2,54]. Large numbers of crosslinks per protein mole-
cule supposedly lead to catching, and stabilising, rare or
artificial protein conformations and interactions, by
‘zippering’ (Figure 3). However, even at very high re-
agent concentrations, homobifunctional NHS-ester
crosslinking reagents perturb protein structure only
locally, with global folding relatively unscathed [55,56].
On the other hand, crosslinking with semispecific
photoactivatable reagents is typically carried out with
lower reagent concentrations than normal homobifunc-
tional NHS-ester crosslinking, with high-density infor-
mation resulting from the aggregated data of many
individual protein molecules [28,35]. Zippering instead
appears to be linked to reaction kinetics, rather than the
number of crosslinks per molecule.
The reaction kinetics of crosslinker reactive groups is a
concept that has recently been garnering more attention
with regards to protein crosslinking reactions [55,57]. In
short, the two relevant key factors of the reactive group
are reaction rate and half-life. The NHS-ester group is
highly reactive with a long half-life, consequently wait-
ing for protein to come close enough for capture. This
makes homobifunctional NHS-crosslinkers susceptible
to zippering. The diazirine photoactivatable group
however, produces an extraordinarily reactive (order of
nanoseconds) carbene radical upon photoactivation,
with an almost nonexistent half-life [58]. This indis-
criminate and fast reaction therefore accurately captures
protein states and interactions [54,59]. Taking reactivity
in the other direction, the sulfur fluoride exchange
(SuFEx) clickable group [60] has a much lower reac-
tivity than NHS-ester, thus requiring longer-lived con-
tacts and therefore not catching short-lived protein
states [61]. Considering reaction kinetics and not only
the reaction specificity of reactive groups, suggests a
strong future for reactive groups complementary to the
NHS-ester and the importance of data-driven cross-
linker design.Spacer functionality
The spacer can act as a scaffold for functionalities that
address the low abundance and complexity of analytes,
characteristics of crosslinking products that challenge
analysis. Functionality includes MS-cleavable groups,
isotope-coding, enrichment handles and related capture
and release groups. Modular design approaches applied
to crosslinker synthesis can be used to create reagents
combining multiple functional groups [62]. This is
where the range of applicable chemistry also greatly
expands. This is demonstrated in the PIR crosslinkers
[63] (Figure 1), azide/alkyne-A-DSBSO [64], CBDPSCurrent Opinion in Chemical Biology 2021, 60:39–46
Figure 3
Consequences of reactive group chemistry in crosslinkers. (a) Semi-
specific photocrosslinkers can increase crosslink data density (the protein
sequence is represented by a grey circular line; the crosslinks are
represented as internal lines) by expanding reactivity to all amino acid
residues. Photocrosslinkers such as SDA contain lysine (and S/T/Y)
reactive NHS-esters on one side (blue circle). The photoactivatable
reactive group (red circle) on the other side can react with any amino acid.
The reaction specificity of standard homobifunctional NHS-ester–based
42 Omics
Current Opinion in Chemical Biology 2021, 60:39–46[65] and Leiker [66], which have seen application suc-
cess including proteome-wide analyses [64,67,68].
MS-cleavable groups include multiple classes of bonds,
which cleave upon collisional activation in the mass
spectrometer and have been incorporated into
numerous crosslinkers. MS-cleavable crosslinkers have
been reviewed extensively [2,3,69]. The concept of MS-
cleavability is proposed as important for proteome-wide
analyses [52,70e72]. Other comparable proteome-wide
studies however, have relied simply on DSS/BS3
[22,23,28]. This leads to the question of where the real
gains of MS-cleavable groups can be achieved versus the
conceptual benefits. Contributing to this, it is still un-
clear to what extent available reagents realise the
concept. MS-cleavable reagents will not cleave with the
same efficiency between all crosslinked peptides, an
aspect that original proof-of-concept studies did not
investigate and that urgently demands to be quantified.
Assuming perfect behaviour when designing acquisition
or search strategies will come at the cost of excluding a
potentially large number of crosslinked peptides that
cleave with lower efficiency than selected examples.
Furthermore, the data obtained using noncleavable re-
agents can be computationally dissected into contribu-
tions of the individual peptides [73]. This
computational ‘cleavage’ blurs the distinction between
MS-cleavable and other crosslinkers and increases the
need for more rigorous experimental validation.
Enrichable groups have also been used in crosslinkers
(sometimes in combination with MS-cleavable groups),
for proteome-wide analyses [64,67,68]. The predomi-
nant enrichment group used in the spacer of crosslinkers
is biotin [62e66,74e80], which exploits the remarkably
high affinity of the avidinebiotin complex. Biotinylated
crosslinked peptides can be isolated on a solid-
supported avidin derivative (including monomeric
avidin, streptavidin and neutravidin), with the
streptavidinebiotin interaction being the strongest
noncovalent biological interaction known
(Kdw 10
15 M). This extremely high affinity presents a
problem however, when release from the solid support is
required [81]. It is unclear what is the extent of recovery
from streptavidin using organic solvent elution alone
[74,77,79]. Solid-supported monomeric avidin, with a
far lower binding affinity with biotin (Kd w 10
7 M),
represents a compromise [63,65,75,76,78]. Other at-
tempts to overcome the problem of release from the
solid support have been to include release groups be-
tween the biotin and the rest of the crosslinker back-
bone [62,64,66,80]. These include polyethylene glycol
(PEG, which is hydroxylamine-cleavable) [62], pinacol
esters (acid-cleavable) [64], azobenzene (cleaved by
sodium dithionate reduction) [66], disulphide (reduc-
tive-cleavage) [80] and photocleavable groups [66].
Click chemistry groups have been proposed as both
capture groups for coupling a biotin enrichment groupwww.sciencedirect.com
crosslinkers, targets lysines (and S/T/Y residues to a lesser extent) only.
This limited specificity also limits the density of resulting crosslink net-
works. (b) Rare protein conformations and interactions are over-
represented by homobifunctional NHS-ester–based crosslinkers. The
long half-life yet still fast reaction rate of the NHS-ester reactive group,
allows capturing rare conformations (on the timescale of typical protein
dynamics) by apparent zippering. Photocrosslinkers generate reactive
radicals with vanishingly short half-life and consequently do not “wait” until
protein is nearby. Therefore protein populations of mixed conformations
are captured accurately. (c) The relative reaction rates and half-lives of the
diazirine (red circle), NHS-ester (blue circle) and SuFEx (orange circle)
reactive groups.
Anatomy of a crosslinker Belsom and Rappsilber 43after crosslinking [64,78], and as enrichment groups in
their own right [64,82,83], with reversibility achieved
via an acid-cleavable acetal [64,83] or disulphide [82].
Recently, a different enrichment group, a negatively
charged phosphonic acid, was developed into a cross-
linker reagent [84]. This simple, small and short cross-
linker is a refreshing exception to the biotin/Click
chemistry conundrum and the trend towards functional
crosslinker expansion. Paradoxically though, the nega-
tive charge prevents the crossing of cell membranes for
in-cell crosslinking, a major application goal that thirsts
for enrichment.
The impressive array of chemistry applied to cross-
linking reagents in the quest for crosslinker enrichment
shows that synthesis of even protracted functionality is
possible. What is not yet clear is whether increasing
functionality guarantees or translates into improved
identification of crosslinked analytes, that is, greater
information content which might be reached by
increased number of crosslinks (quantity) at maintained
confidence (quality) but also different types of cross
links (kinetics, selectivity). A concern is that increasing
and combining functional chemistry into larger cross-
linking reagents could end up burdening analysis, owing
to issues such as increased hydrophobicity, unexpected
side reactions, inefficient reactions, complicated frag-
mentation spectra and other related causes of analyte or
information losses.Conclusion
The power and potential of crosslinking-MS has been
thoroughly established. Extensive claims regarding
conceptual gains, through the use of crosslinker chem-
istry and consequent functional groups, have been made
repeatedly. Crosslinker anatomical concepts including
MS-cleavability and enrichment have potential, but the
benefits must be demonstrated clearly. This must be
done in order to move forward with developing betterwww.sciencedirect.comperforming crosslinkers and optimal combinations of
functionality.
Functional groups applied in crosslinkers need to be
thoroughly tested, characterised and proven specifically
in the context of crosslinking-MS. A larger focus on data
is urgently needed, to enable data-driven crosslinker
design. An important element of this is the inclusion of
statistical data as part of proof-of-concept studies to
complement cherry-picked examples, which would also
include providing open and stable access to the raw data.
One way this could be done is through synthetic peptide
libraries [50].
The increased appeal of crosslinking-MS, means that
many scientists now want to apply crosslinking-MS as a
tool to answer their own structural biology questions.
However, they must first navigate concepts when
deciding which crosslinker reagent to choose for their
application. It is possible that an ideal crosslinker
already exists, despite crosslinker developers continuing
to churn out new variants. But without proving concepts
through data, crosslinker developers are unable to make
concrete suggestions or convince crosslinking MS users
to apply their crosslinker reagents with confidence. A
consequence is that researchers will err on the side of
caution, opting for the simplicity of homobifunctional
NHS-ester based crosslinkers such as BS3 and DSS.
Crosslinking reagents are of course essential but still
only one of the critical pieces of the crosslinking MS
machinery, which also relies on MS, software engineer-
ing, data processing and analysis, data visualisation and
integration with structural biology. Ultimately the true
test of crosslinker chemistry will be through the appli-
cations that are achieved and the discoveries that will be
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